Non-CHD group (n = 58) | CHD group (n = 242) | T/χ2 | P | |
---|---|---|---|---|
Age, y | 58.86 ± 8.03 | 65.76 ± 8.46 | 5.628 | < 0.001 |
Smoking, No | 7 (12.07%) | 18 (7.44%) | 1.708 | 0.252 |
Overweight a, No | 19 (32.76%) | 65 (26.86%) | 1.327 | 0.369 |
Diabetes, No | 19 (32.76%) | 104 (42.98%) | 2.022 | 0.155 |
Hypertension, No | 34 (58.62%) | 143 (59.09%) | 0.981 | 0.948 |
Family history b, No | 11 (18.97%) | 37 (15.29%) | 1.297 | 0.493 |
TIMI Flow 0-I c, No | 0 (0.00%) | 32 (13.22%) | 8.585 | 0.003 |
TG (mg/dL)* | 133.92 (106.85, 200.46) | 148.82 (100.94, 209.08) | 0.394 | 0.694 |
ApoA1 (mg/dL) | 134.31 ± 15.94 | 130.41 ± 15.74 | 1.693 | 0.092 |
ApoB (mg/dL)* | 77.91 (58.51, 89.86) | 82.10 (68.75, 98.49) | 2.839 | 0.005 |
TC-p (nmol/L)* | 1416.58 (1063.81, 1633.81) | 1492.63 (1250.06, 1790.84) | 2.839 | 0.005 |
TC (mg/dL) | 168.16 ± 38.43 | 177.74 ± 38.68 | 1.696 | 0.091 |
Lp(a)-p (nmol/L)* | 42.80 (16.35, 93.88) | 36.40 (13.40, 80.00) | 0.801 | 0.424 |
Lp(a) (mg/dL)* | 17.83 (6.81, 39.12) | 14.96 (5.42, 33.12) | 0.801 | 0.424 |
LDL-p (nmol/L) | 1042.17 ± 360.58 | 1168.91 ± 366.35 | 2.374 | 0.018 |
LDL-C (mg/dL) | 81.15 ± 32.77 | 87.30 ± 30.60 | 1.354 | 0.177 |
LDL-size (nm)* | 20.44 (20.23, 20.68) | 20.37 (20.17, 20.61) | 1.634 | 0.103 |
LDL-p-corr (nmol/L) | 977.50 ± 357.33 | 1108.44 ± 366.46 | 2.456 | 0.015 |
LDL-C-corr (mg/dL) | 73.10 ± 32.30 | 79.76 ± 30.41 | 1.481 | 0.140 |
HDL-p (nmol/L)* | 73.35 (45.78, 121.62) | 78.87 (51.55, 114.60) | 0.747 | 0.455 |
HDL-C (mg/dL)* | 45.81 (38.86, 55.28) | 45.23 (40.46, 50.51) | 0.877 | 0.381 |
Non-HDL-p (nmol/L) | 1300.29 ± 381.68 | 1463.23 ± 424.55 | 2.675 | 0.008 |
Non-HDL-p-corr (nmol/L) | 1235.62 ± 377.88 | 1402.76 ± 426.11 | 2.740 | 0.007 |
Non-HDL-C (mg/dL) | 120.62 ± 34.74 | 131.50 ± 37.68 | 2.004 | 0.046 |
Non-HDL-C-corr (mg/dL)* | 112.53 (84.79, 136.45) | 116.96 (96.00, 147.17) | 2.148 | 0.033 |